Compliance with medication regimens for mental and physical disorders.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Psychiatric Services

• Publication date

  1998-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/PS.49.2.196PMID 9575004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamics of drug regimen compliance — its assessment by microprocessor-based monitoring

  2004cited by this paper
• Dosage frequency and drug-compliance behaviour — a comparative study on compliance with a medication to be taken twice or four times daily

  2004cited by this paper
• Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring

  2004cited by this paper
• Magnitude and Nature of Noncompliance with Treatment using Isosorbide Dinitrate in Patients with Ischemic Heart Disease

  1996cited by this paper
• From compliance to alliance. A quarter century of research.

  1996cited by this paper
• Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta‐analysis

  1995cited by this paper
• Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi.

  1995cited by this paper
• Compliance with treatment in schizophrenia: a drug intervention program in a developing country

  1995cited by this paper
• Microelectronic Systems for Monitoring and Enhancing Patient Compliance With Medication Regimens

  1995cited by this paper
• Long-term patient compliance with prescribed regimens of calcium channel blockers.

  1994cited by this paper
• The compliance with antidepressants in general practice

  1994cited by this paper
• Compliance with antipsychotic drug treatment: influence of side effects.

  1994cited by this paper
• Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care.

  1994cited by this paper
• Predicting Medication Compliance in a Psychotic Population

  1993cited by this paper
• The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening

  1993cited by this paper
• Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.

  1993cited by this paper
• The Prevalence and Nature of Lithium Noncompliance among Chinese Psychiatric Patients in Hong Kong

  1993cited by this paper
• Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog.

  1993cited by this paper
• Variable patient compliance in ambulatory trials--nuisance, threat, opportunity.

  1993cited by this paper
• Out-patient Compliance with Antidepressant Medication

  1992cited by this paper
• A two-year prospective study of treatment compliance in patients with schizophrenia

  1992cited by this paper
• Compliance assessed by the Medication Event Monitoring System.

  1991cited by this paper
• Compliance declines between clinic visits.

  1990cited by this paper
• Medication Compliance and Health Education Among Outpatients With Chronic Mental Disorders

  1990cited by this paper
• How often is medication taken as prescribed? A novel assessment technique.

  1989cited by this paper
• Pill count measures of compliance in a drug trial: variability and suitability.

  1988cited by this paper
• Compliance with topical pilocarpine treatment.

  1986cited by this paper
• Information, compliance and side-effects: a study of patients on antidepressant medication.

  1984cited by this paper
• Drug-Related Admissions to a Veterans' Administration Psychiatric Unit

  1984cited by this paper
• Adherence to treatment regimen in a lithium carbonate clinic.

  1982cited by this paper
• Relapse in schizophrenia.

  1980cited by this paper
• A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia

  1978cited by this paper
• Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics.

  1978cited by this paper
• Why do schizophrenic patients refuse to take their drugs?

  1974cited by this paper
• Editorial: Single daily dose of antidepressants.

  1974cited by this paper
• Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambulatory treatment.

  1974cited by this paper
• Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates.

  1973cited by this paper
• Phenothiazine intake and staff attitudes.

  1971cited by this paper
• Trial of Maintenance Therapy in Schizophrenia*

  1971cited by this paper
• Use of antipsychotic and antidepressant drugs by chronically ill patients.

  1970cited by this paper
• Do psyhiatric out-patients take their drugs?

  1965cited by this paper
• A FOLLOW‐UP OF SCHIZOPHRENIC PATIENTS IN EDINBURGH

  1963cited by this paper
• A preliminary report on the continued post-hospital use of tranquilizing drugs.

  1961cited by this paper
• Side-effects, resistance and dosage deviations in psychiatric outpatients treated with tranquilizers.

  1961cited by this paper
• A comparison of acceptors and resistors of drug treatment as an adjunct to psychotherapy.

  1961cited by this paper
• The effect of chlorpromazine in reducing the relapse rate in 716 released patients: study 3.

  1958cited by this paper
• Why patients leave psychotherapy.

  1957cited by this paper

• Patterns and predictors of the transition between minimally adequate treatment and effective treatment coverage for mental disorders: results from the World Mental Health Survey.

  2026cites this paper
• Non-adherence level of pharmacotherapy and its predictors among mental disorders in a resource-limited life trajectories: a systematic review and meta-analysis

  2025cites this paper
• Assessment of Potential Factors Influencing Attention-Deficit/Hyperactivity Disorder Drug Adherence: A Database Study

  2025cites this paper
• Pharmacogenomics-guided treatment versus conventional treatment in patients with Schizophrenia: Evaluation of medication adherence and switching rate

  2025cites this paper
• Financial incentives to improve adherence to medication in five patients with schizophrenia in the Netherlands.

  2025cites this paper
• Effective Treatment for Mental and Substance Use Disorders in 21 Countries.

  2025cites this paper
• Non-adherence with the treatment regimen and its associated factors among patients with schizophrenia in Sub-Saharan Africa: a systematic review and meta-analysis

  2025cites this paper
• Psychotropic medication non-adherence and its determinants among people living with mental illnesses in Ethiopia: systematic review and meta-analysis study

  2025cites this paper
• Motivational Interviewing in Patients with Acute Psychosis: A Feasibility Study

  2025cites this paper
• Proceed with Caution: Pre-op and Post-op Signs for Every Plastic Surgeon to Know.

  2025cites this paper
• Differences in the relationship between medication adherence and payer medical costs across three quality measures: results of a cohort study among medicare advantage beneficiaries

  2025cites this paper
• Clinical pharmacy activities specific to patients treated with lithium.

  2025cites this paper
• Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study

  2025cites this paper
• Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients' subjective experiences.

  2025cites this paper
• Acceptability, User Satisfaction, and Feasibility of an App-Based Support Service During the COVID-19 Pandemic in a Psychiatric Outpatient Setting: Prospective Longitudinal Observational Study

  2024cites this paper
• Association of schizophrenia with fracture‐related femoral neck displacement: A cross‐sectional retrospective study

  2024cites this paper
• Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort

  2024cites this paper
• Engagement and retention in digital mental health interventions: a narrative review

  2024cites this paper
• Protective effects of psychiatric medications against COVID-19 mortality before vaccines

  2024cites this paper
• Coping strategies and adherence in people with mood disorder: a cross-sectional study

  2024cites this paper
• Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine

  2024cites this paper
• Appropriate use of single-dose injectable aripiprazole lauroxil in the treatment of schizophrenia

  2024cites this paper
• Interventions to improve medication adherence in adults with mental–physical multimorbidity in primary care: a systematic review

  2024cites this paper
• A systematic review of approaches to improve medication adherence in homeless adults with psychiatric disorders

  2024cites this paper
• Initiation of Antipsychotics During the First Year After First‐Episode Psychosis: A Population‐Based Study

  2024cites this paper
• Healthcare costs associated with receipt of effective mental healthcare coverage in individuals with moderate or severe symptoms of anxiety and depression

  2024cites this paper
• KETO-MOOD: Ketogenic Diet for Microbiome Optimization and Overcoming Depression – A Protocol for a Randomized Controlled Trial

  2024cites this paper
• Bilateral hypothalamotomy plus dominant amygdalotomy with Gamma Knife radiosurgery. A non-invasive alternative when everything has failed in the management of aggressive behavior disorder

  2024cites this paper
• Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization

  2023cites this paper
• How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients

  2023cites this paper
• Assessment of the attitude toward medication and reasons for drug compliance among schizophrenic patients attending the tertiary care hospital

  2023cites this paper
• Brilaroxazine (RP5063), a Novel Serotonin-Dopamine Stabilizer, Displays Antipsychotic Efficacy in Rodents

  2023cites this paper
• Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression: Secondary neuroimaging findings of a randomized controlled trial.

  2023cites this paper
• Towards measuring effective coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder in São Paulo metropolitan area, Brazil

  2023cites this paper
• Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis

  2023cites this paper
• Correlation Between Efficacy of Treatment with Anti-psychotics and Adherence in Schizophrenic Patients: A Cross-sectional Study in Saudi Arabia

  2023cites this paper
• Acceptability, feasibility, and user satisfaction of a virtual reality relaxation intervention in a psychiatric outpatient setting during the COVID-19 pandemic

  2023cites this paper
• Determinants of effective treatment coverage for posttraumatic stress disorder: findings from the World Mental Health Surveys

  2023cites this paper
• Which Severe Mental Illnesses Most Increase the Risk of Developing Dementia? Comparing the Risk of Dementia in Patients with Schizophrenia, Major Depressive Disorder and Bipolar Disorder

  2023cites this paper
• Trauma-focused therapy in early psychosis: results of a feasibility randomized controlled trial of EMDR for psychosis (EMDRp) in early intervention settings.

  2023cites this paper
• Adherence of patients with schizophrenia to hypothyroidism treatment

  2023cites this paper
• Patient’s Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study

  2023cites this paper
• Identifying risk factors to predict violent behaviour in community patients with severe mental disorders: A retrospective study of 5277 patients in China.

  2023cites this paper
• Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder.

  2023cites this paper
• Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital

  2023cites this paper
• Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review

  2023cites this paper
• Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series

  2023cites this paper
• Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets

  2023cites this paper
• Psychotropic Medication Adherence and Its Associated Factors Among Schizophrenia Patients: Exploring the Consistency of Adherence Scales

  2023cites this paper
• Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial

  2023cites this paper
• Mimicry boosts social bias: unrealistic optimism in a health prevention case

  2023cites this paper
• Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial

  2022cites this paper
• Towards measuring effective treatment coverage: critical bottlenecks in quality-and user-adjusted coverage for major depressive disorder

  2022cites this paper
• PPA_A_343211 373..401

  2022cites this paper
• A Pilot Remote Drama Therapy Program Using the Co-active Therapeutic Theater Model in People with Serious Mental Illness

  2022cites this paper
• Determinants of effective treatment coverage for major depressive disorder in the WHO World Mental Health Surveys

  2022cites this paper
• The association between birth weight, ponderal index, psychotropic medication, and type 2 diabetes in individuals with severe mental illness.

  2022cites this paper
• Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice: A Pooled Analysis

  2022cites this paper
• Passive Mobile Self-Tracking of Mental Health by Veterans with Serious Mental Illness: Study Protocol (Preprint)

  2022cites this paper
• Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers

  2022cites this paper
• Antipsychotic-Related Stigma and the Impact on Treatment Choices: A Systematic Review and Framework Synthesis

  2022cites this paper
• Telemedicine as a Tool to Improve Medicine Adherence in Patients with Affective Disorders – A Systematic Literature Review

  2022cites this paper
• Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia

  2022cites this paper
• Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic

  2022cites this paper
• Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study

  2022cites this paper
• A Digital Intervention Using Daily Financial Incentives to Increase Medication Adherence in Severe Mental Illness: Single-Arm Longitudinal Pilot Study

  2022cites this paper
• Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.

  2022cites this paper
• Use of an Ingestible, Sensor-Based Digital Adherence System to Strengthen the Therapeutic Relationship in Serious Mental Illness

  2022cites this paper
• "Wellness for the Wounded: Mental Healthcare in the Diabetic Limb Salvage Team."

  2022cites this paper
• S0033291720003797jra 1948..1958

  2022cites this paper
• Passive Mobile Self-tracking of Mental Health by Veterans With Serious Mental Illness: Protocol for a User-Centered Design and Prospective Cohort Study

  2022cites this paper
• Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

  2022cites this paper
• Identification of Effective Factors in Recurrence of Schizophrenia Spectrum Disorder Using Poisson Regression Model

  2022cites this paper
• A Digital Intervention Using Daily Financial Incentives to Increase Medication Adherence in Severe Mental Illness: A Feasibility Study (Preprint)

  2022cites this paper
• The Effect of Pharmacy-Led Medication Reconciliation on Odds of Psychiatric Relapse at a Community Hospital

  2022cites this paper
• [Validation and analysis of the Patient's Health Belief Questionnaire on Psychiatric Treatment in a sample of Hungarian psychiatric patients].

  2021cites this paper
• Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study

  2021cites this paper
• Medication Adherence and Drug Attitude Amongst Male Patients with the Methamphetamine-Induced Psychotic Disorder After Discharge: A Three Months Follow Up Study

  2021cites this paper
• Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

  2021cites this paper
• Treatment Adherence

  2021cites this paper
• Risperidone for Extended-Release Injectable Suspension (Perseris)

  2021cites this paper
• Comparison of Hospitalization Rate and Social Functioning of Patients Receiving Community Mental Health Service and Outpatient Psychiatry Policlinic.

  2021cites this paper
• You Want to Know the Truth? Then Don’t Mimic!

  2021cites this paper
• Schizophrenia and Hospital Admissions for Cardiovascular Events in a Large Population: The APNA Study

  2021cites this paper
• Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis

  2021cites this paper
• Irritability, Anger, and Aggression in the Context of Pediatric Bipolar Disorder.

  2021cites this paper
• Religiosity and treatment adherence among out-patients with schizophrenia

  2021cites this paper
• Interventions to Improve Medication Adherence in Patients with Schizophrenia or Bipolar Disorders: A Systematic Review and Meta-Analysis

  2021cites this paper
• Working with People with Mental Health Difficulties to Improve Adherence to Medication

  2020cites this paper
• Attitudes of European physicians towards the use of long-acting injectable antipsychotics

  2020cites this paper
• Telemedizin in der Psychiatrie

  2020cites this paper
• Drugs to Treat Depression.

  2020cites this paper
• EEG Changes in Patients with Functional Psychosis in Babylon Province

  2020cites this paper
• Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case–control study in Korea

  2020cites this paper
• Eye movement desensitization and reprocessing therapy for psychosis (EMDRp): Protocol of a feasibility randomized controlled trial with early intervention service users

  2020cites this paper
• Compliance of Familial Mediterranean Fever Patients With Regular Follow-up Visits and Associated Factors

  2020cites this paper
• Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis

  2020cites this paper
• Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia

  2020cites this paper
• Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies.

  2020cites this paper
• Association of antipsychotics adherence and cardiovascular disease among newly diagnosed schizophrenia patients: A national cohort among Koreans.

  2020cites this paper